Oxidative stress is linked to many pathological conditions including the loss of dopaminergic neurons 13 in Parkinson's disease. The vast majority of disease cases appear to be caused by a combination of 14 genetic mutations and environmental factors. We screened for genes protecting Caenorhabditis 15 elegans dopaminergic neurons from oxidative stress induced by the neurotoxin 6-hydroxydopamine 16 (6-OHDA) and identified the transthyretin-related gene ttr-33. The only described C. elegans 17 transthyretin-related protein to date, TTR-52, has been shown to mediate corpse engulfment as well 18 as axon repair. We demonstrate that TTR-52 and TTR-33 have distinct roles. TTR-33 is likely 19 produced in the posterior arcade cells in the head of C. elegans larvae and is predicted to be a 20 secreted protein. TTR-33 protects C. elegans from oxidative stress induced by paraquat or H 2 O 2 at an 21 organismal level. The increased oxidative stress sensitivity of ttr-33 mutants is alleviated by 22
mutations affecting the KGB-1 MAPK kinase pathway, whereas it is enhanced by mutation of the 23 JNK-1 MAPK kinase. Finally, we provide genetic evidence that the C. elegans cell corpse engulfment 24 pathway is required for the degeneration of dopaminergic neurons after exposure to 6-OHDA. In 25 summary, we describe a new neuroprotective mechanism and demonstrate that TTR-33 normally 26 functions to protect dopaminergic neurons from oxidative stress-induced degeneration, potentially 27 by acting as a secreted sensor or scavenger of oxidative stress. 28 29 Introduction 6-OHDA sensitivity of ttr-33 mutant hypersensitivity occurs in the first larval stages and is inhibited 140 by blocking neuronal drug uptake 141 TTR-33, like the majority of the C. elegans transthyretin-related proteins [24] , is predicted to be a 142 secreted, non-cytoplasmic protein (S2A Fig) . Apart from the small alpha-helical signal peptide at the 143 N-terminus, the predicted TTR-33 protein structure is composed predominantly of beta sheets (Fig 144 2A; S2C Fig) . According to this protein structure prediction, ttr-33(gt1983) and ttr-33(gk567379) lead 145 to amino acid changes on two neighbouring beta-strands (Fig 2A) . 146
To determine the developmental stages in which ttr-33 functions to protect C. elegans from 6-147 OHDA-induced neurodegeneration, we exposed a mixed population of ttr-33 mutants to this drug. 148
The larval stages 1-4 (L1-L4) and adult animals were separated after treatment. We found that L1 149 and L2 ttr-33 mutant larvae were highly sensitive to 6-OHDA, whereas L3 larvae exhibited less 150 sensitivity ( Fig 2C) . Mutant L4 larvae and adults did not show increased neurodegeneration ( Fig 2C) . 151
We conclude that loss of function of ttr-33 causes 6-OHDA-induced dopaminergic 152 neurodegeneration in the first three larval stages of C. elegans. 153 ttr-33 mutant animals develop at a slightly slower rate than wild-type animals (S3A Fig) , but do not 154 exhibit increased growth delays after exposure to 6-OHDA ( Fig 2B) . Thus, ttr-33 mutants exhibit 155 highly increased dopaminergic neurodegeneration at a concentration of 6-OHDA that does not affect 156 their overall development. We also examined whether the ttr-33 mutation affects dopaminergic 157
signalling, yet we found that ttr-33(gt1983) mutants behave like wild-type animals in assays testing 158 dopamine-mediated behaviours (S3A and S3B Fig) . Finally, ttr-33 mutants do not exhibit loss of 159 dopaminergic neuron when the uptake of 6-OHDA into these cells is prevented by deletion of the 160 dopamine transporter dat-1 ( Fig 2D) . 161
TTR-33 acts independently of TTR-52 162
We next asked whether TTR-33 and the previously characterised have analogous 163 roles in neuroprotection and axon repair. To test genetic interactions, we also performed 164 experiments with lower concentrations of 6-OHDA to be able to detect possible enhanced 165 neurodegeneration due to synergic effect (S4A Fig) . We found that a ttr-52 loss-of-function mutation 166 did not cause increased 6-OHDA-induced neurodegeneration and did not influence the sensitivity of 167 ttr-33 mutants or wild-type animals ( Fig 3A, B; S4B and S4C Fig) . Thus, TTR-52 does not appear to 168 play a role in 6-OHDA-induced dopaminergic cell loss. In addition, we performed laser axotomy on 169 the PLM (posterior lateral microtubule cells) mechanosensory neurons of wild-type and ttr-33 170 mutant animals, using animals carrying the zdIs5 transgene that express GFP under the control of 171 the mechanosensory neuron-specific mec-4 promoter. We found that PLM axons of ttr-33 mutants 172 did not show overt defects in the rate of axonal regrowth, reconnection or fusion after injury ( Fig 3C  173 and C'), unlike ttr-52 mutants which have been shown to present a defect in axonal fusion [27] . In 174 summary, TTR-52 and TTR-33 function appear to have specific and independent functions. 175
The cell corpse engulfment pathway is required for 6-OHDA-induced dopaminergic neuron death 176
Given the reported role of TTR-52 in corpse engulfment, we asked if the cell corpse engulfment 177 machinery influences 6-OHDA-induced neurodegeneration. The phagocytosis pathway consists of 178 two partially redundant branches (for a simplified model see Fig 4A which was adapted from [27] ). 179
One branch involves the TTR-52 bridging molecule, the CED-1 receptor and the CED-6 adaptor 180 protein. The second pathway involves the CED-2 SH2 and SH3 domain-containing adaptor protein, 181 and the activation of the CED-10/RAC protein via the bipartite CED-5 and CED-12 guanine nucleotide 182 exchange factor. CED-10 acts as the end point of both pathways ( Fig 4A) . We found that mutation in 183 ced-6, in contrast to mutation in ced-2, led to a measurable suppression of dopaminergic 184 neurodegeneration in the ttr-33 mutant background ( Fig 4B; S5A Fig) . Furthermore, 33 triple mutants and ced-10;ttr-33 double mutants in which both pathways are disrupted, showed 186 an increased suppression of dopaminergic neuron death compared with ced-6;ttr-33 alone ( Fig 4B) . 187
Finally, we also observed a reduction in dopaminergic neuron loss in a wild-type background (Fig 4C; 188 S5B Fig) . Thus, both branches of the cell corpse engulfment pathway are required for 6-OHDA-189 induced dopaminergic neuron loss. We note that TTR-52, which has a role in engulfing apoptotic 190 cells in the CED-5 pathway, had no discernible role in 6-OHDA-induced dopaminergic 191 neurodegeneration. 192 ttr-33 is likely expressed in pharynx, hypodermis and in posterior arcade cells 193 TTR-33 is predicted to be a secreted protein and a transcriptional reporter is thus expected to 194 highlight the location of protein production. We examined three independent transgenic strains 195 carrying transcriptional Pttr-33::gfp reporter, and found that six cells residing in the head of L1 196 larvae were strongly labelled ( Fig 5A-B) . Two of the labelled cells were located next to the first 197 pharyngeal bulb and four were situated halfway between the mouth and the first pharyngeal bulb. 198
All six cells form protrusions towards the mouth of the larva. The cells were labelled as early as in 199 the embryonic pretzel stage ( Fig 5C; S1 Movie) . Comparison with the cell atlas of C. elegans [30] and 200 a GFP reporter under the control of the grl-27 arcade cell-specific promoter [31] revealed that these 201 cells represent most likely the posterior arcade cells, which are located between external epidermis 202 and anterior pharynx [32] . In support of this notion, we found that expression of wild-type TTR-33 203 under the arcade cell-specific promoter of bath-15 (C08C3.2) led to a partial rescue of the defect of 204 ttr-33 mutant animals ( Fig 1F) . In addition, in L1 stage larvae, ttr-33 expression was observed in the 205 pharynx and in several unidentified cells immediately posterior to the second pharyngeal bulb. In 206 older animals, the Pttr-33::GFP transcriptional reporter highlights head cells next to and anterior of 207 the first pharyngeal bulb, as well as the pharynx and the hypodermis (S2-S5 Movie). Given that 208 expression of wild-type TTR-33 under the control of its endogenous regulatory region as well as the 209
Pbath-15 promoter was not sufficient to fully rescue the enhanced neurodegeneration in ttr-33 210 mutants, it remains possible that the endogenous gene is expressed in further tissue not visible in 211 these transgenic lines. 212
ttr-33 mutants are sensitive to oxidative stress 213
To determine if ttr-33 mutants are also sensitive to oxidative stress at an organismal level, we 214 exposed the L1 stage larvae to different concentrations of paraquat and hydrogen peroxide (H 2 O 2 ) 215 for 1 hour. We found that after treatment with paraquat ( Fig 6A) and H 2 O 2 (Fig 6B) , the development 216 of ttr-33 mutants is compromised compared with wild-type animals. Since increased oxidative stress 217 has been connected to premature aging (for review [1, 33] ), we asked whether the lifespan of ttr-33 218 mutants was altered and found that these animals are indeed short-lived ( Fig 6C, S6 Fig) . We next 219 investigated if ttr-33 is transcriptionally regulated in response to oxidative stress using qRT-PCR and 220 found that this does not appear to be the case (S7A, I Fig; S8A, I Fig) . Furthermore, to determine if 221 oxidative stress signalling is altered in ttr-33 mutants as compared to wild-type animals, we 222 measured expression of the oxidative stress reporters gst-1, gst-4 and gcs-1. We found that the ttr-223 33(gt1983) mutant does not show overt differences in gst-1, gst-4 and gcn-1 mRNA expression after 224 whereas the JNK-1 MAP kinase pathway provides additional protection. In addition, we find that the 249 corpse engulfment pathway is required for 6-OHDA-mediated dopaminergic neurodegeneration. 250
We speculate that TTR-33 is part of an endocrine defence system against oxidative stress. 251
Transthyretin-related proteins form a nematode-specific expanded protein family that comprises 59 252 members, 54 of which are predicted to be secreted [24] . Some transthyretin-related genes are 253 induced in response to environmental challenges such as oxidative stress or pathogen exposure: 254
Oxidative stress induced by tert-butyl hydrogen leads to upregulation of several transthyretin-255 related genes [35] , and treatment with the mitochondrial complex I inhibitor rotenone leads to the 256 upregulation of 42 of the 59 transthyretin-related genes [36] . Furthermore, bacterial infection was 257 reported to cause upregulation of ttr-33 [37] and other transthyretin-related proteins [38] . However, 258
we found that TTR-33 does not appear to be induced in response to oxidative stress and thus might 259 provide constitutive protection. TTR-33 possesses 4 cysteine residues that are conserved within the 260 C. elegans transthyretin-related protein family (marked in yellow in S2B Fig and S11 Fig) . These 261 cysteines could serve as reactive oxygen sensors or scavengers, analogous to those in the 262 antioxidant glutathione. TTR-33 is likely produced in the six posterior arcade cells, which form a 263 syncytium and are located between outer epidermis and the pharynx [32] and TTR-33 could be 264 secreted from the arcade cells into the pharynx. This hypothesis is consistent with the partial rescue 265 we observed upon expressing TTR-33 from an arcade cell-specific promoter. In the pharynx, TTR-33 266 could provide organismal protection against ingested oxidative stress-producing compounds. It will 267 be interesting to experimentally investigate the mechanistic details of TTR-33 function in the future. 268 ttr-33 gene expression correlates with genes that are associated with the gene ontology terms 269 'defence response to fungus', 'negative regulation of metalloenzyme activity' and 'neuropeptide 270 signalling pathway' (S1 Table) . ttr-33 mutants die prematurely and are hypersensitive to oxidative 271 stress at an organismal level, supporting the idea that these animals might exhibit a compromised 272 organismal defence system (reviewed in [39] ). Alternatively, mutation of ttr-33 could generally lower 273 the threshold of oxidative damage both for dopaminergic neurons as well as at an organismal level. 274
We hypothesise that the KGB-1 and the JNK-1 MAPK pathways influence 6-OHDA-mediated 275 neurodegeneration in the ttr-33 mutant based on their role in organismal stress responses. KGB-1 is 276 ubiquitously expressed [40, 41] and was reported to transmit a neuroendocrine signal that mediates 277 a food aversion behaviour upon disruption of core cellular processes such as translation, respiration 278 and protein turnover [42] . It is conceivable that KGB-1 acts upstream of TTR-33. However, the kgb-1 279 mutant on its own does not show enhanced 6-OHDA-induced neuronal loss. It is thus possible that 280 the KGB-1 pathway senses the pathology conferred by the combination of exposure to oxidative 281 stress and TTR-33 deficiency analogous to its described roles in sensing cellular defects [42] . Such 282 sensing mechanisms might promote the degeneration of damaged neurons. In contrast, the JNK 283 orthologues JNK-1 protects against 6-OHDA-induced neurodegeneration in the ttr-33 mutant. This 284 phenotype is consistent with the reported role of JNK-1 in protecting against oxidative stress [43, 44] . 285
The C. elegans corpse engulfment pathway could promote 6-OHDA-induced dopaminergic 286 neurodegeneration by driving the phagocytosis of dopaminergic neurons. Morphological evidence 287 for 6-OHDA-induced engulfment of dopaminergic neurons were reported [13, 45] . However, it is not 288 known exactly how dopaminergic neurons die. The engulfment pathway typically acts by eliminating 289 apoptotic cell corpses, but has also been shown to promote cell death; mutations in the engulfment 290 pathway enhance C. elegans apoptosis defects [15, 17] and a small number of cell deaths are 291 mediated by cell killing conferred by the engulfment machinery [18, 19, 46] . Consistent with our 292 findings, reduced axonal degeneration in neurons whose axons have been severed has been 293 observed in mutants with a defective engulfment machinery [47] . It is still poorly understood how 294 dopaminergic neurons die in Parkinson's disease patients. Active phagocytic cells in the brain are 295 observed in almost all neurological diseases including Parkinson's disease (for review [48, 49] ), as 296 well as in 6-OHDA models of Parkinson's disease (for review [50] ). The C. elegans 6-OHDA model, in 297 which the conserved engulfment pathway has a role in cell removal, might recapitulate important 298 features of this disease. 299
Methods

300
C. elegans strains and maintenance 301
Strains were grown at 20°C unless indicated otherwise. Additional information about alleles in this 302 study is provided by WormBase (www.wormbase.org) [51] . Strains from the Caenorhabditis Genetics 303 Center (CGC) or the National BioResource Project (NBRP) were outcrossed to the BY200 strain to 304 eliminate unlinked mutations and to introduce a green fluorescent protein (GFP) marker for 305 dopaminergic neurons. The strain carrying the second ttr-33 allele gk567379 (generated as part of 306 the Million Mutation project [52]) was identified with WormBase [51] and ordered from CGC. Both 307
The isolated gt1983 mutant and the ttr-33(gk567379) mutant were outcrossed a minimum of six 308 times to the BY200 strain. 309
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Mutagenesis and mapping 363
L4 and young adult staged BY200 animals were mutagenised with 25 mM ethyl methanesulfonate in 364 M9 buffer for 4 hours at 20°C, washed and grown at 15°C overnight on NGM plates seeded with 365 OP50 E. coli. The animals were bleached once they started to lay eggs and the F1 progeny left to 366 hatch overnight in M9. This synchronised F1 population was left to develop on seeded plates until 367 reaching early adult stage. The F1 adults were then washed off in M9 to lay a synchronised 368 population of F2 L1 larvae which were then treated with 10 mM 6-OHDA and screened for 369 dopaminergic neuron loss after 72 hours. Candidates were picked on separate plates, backcrossed at 370 least three times and re-tested for their hypersensitivity to 6-OHDA. The genomic DNA was sent for 371 whole-genome sequencing and SNP mapping was performed as previously described [28, 29] . SNP 372 mapping combined with whole-genome sequencing revealed that the location of the phenotype-373 causing mutation could be narrowed down to an interval between 4 and 9 Mb on chromosome V. 374
This region, besides ttr-33, contained two other exon-altering mutations that were excluded by 375 testing a deletion allele (fbxa-223) and by fosmid injection (F43H9.4). ttr-33 identity was further 376 confirmed by genetic rescue and by complementation testing using the second allele ttr-377 33(gk567379) which was obtained from the CGC. 378
C. elegans assays 379
All assays were performed in a blinded manner. 380
For 6-OHDA assays, 1-10 adult animals were incubated to lay eggs in 70 µL M9 without food on a 381 shaker at 20˚C, 500 rpm for 24-30 h. 10 µL 200 mM ascorbic acid and 10 µL of the respective 6-OHDA 382 5x stock concentration were freshly prepared in H 2 O and added to 30 µL of L1-stage larvae in M9. 6-383 OHDA concentrations were chosen such that differential sensitives of various strains could be 384 efficiently analysed. After 1 hour incubation at 20˚C and shaking at 500 rpm, 150 µL M9 buffer was 385 added to oxidise and inactivate the 6-OHDA. The animals were pipetted to one half of an NGM plate 386 containing a stripe of OP50 bacteria on the opposite half of the plate and adult animals and eggs 387 were picked off to prevent growth of those that were not treated at L1 stage. Plates were incubated 388 at 20˚C before examining the 6-OHDA-induced degeneration using a Leica fluorescent dissecting 389 microscope. Unless otherwise indicated, head dopaminergic neurons (ADE and CEP neurons) were 390 scored 72 hours after treatment in technical duplicates. Posterior deirid (PDE) dopaminergic 391 neurons, which are formed later in L2 stage larvae, did not appear to be affected by 6-OHDA 392 treatment, as previously observed [13] . For treatment of different developmental stages, the 393 respective stages were picked after 6-OHDA treatment from a mixed population of animals. 394
For paraquat and hydrogen peroxide (H 2 O 2 ) assays, 10 µL of the 5x paraquat or H 2 O 2 stock 395 concentration was freshly prepared and added to 40 µL of filtered L1-stage larvae in M9. After 1 396 hour incubation in the shaker, 150 µL M9 buffer was added and the L1 larvae were counted after 397 pipetting approximately 100 of them to a seeded NGM plate. After 24 hours, animals that reached 398 L3 larval stage were examined and scored. 399
For laser axotomy and microscopy, animals were immobilised in 0.05% tetramisole hydrochloride 400 on 3.5% agar pads. Axotomies were performed as previously described [54] , using a MicroPoint 401
Laser System Basic Unit attached to a Zeiss Axio Imager A1 (Objective EC Plan-Neofluar 100X/1.30 Oil 402 M27). Axons were severed in L4 stage animals 50 µm anterior to the PLM cell body, visualised on a 403
Zeiss Axio Imager Z1 microscope equipped with a Photometrics camera (Cool Snap HQ2; Tucson, AZ) 404 and analysed with MetaMorph software (Molecular Devices, Sunnyvale, CA) or Image J. Animals 405 were analysed 24 hours post-axotomy for regrowth, reconnection and fusion. Regrowth was 406 recorded as the length of regenerative growth from the proximal side of the cut site: the proximal 407 axon was traced from the start of regrowth to the tip of the longest regenerative branch using 408 Metamorph software; neurons that underwent axonal fusion were excluded from these 409 quantifications. Axons were deemed to be reconnected when the proximal and distal axons 410 appeared connected and within the same focal plane when observed with a 63X objective. Axonal 411 fusion was defined as proximal-distal reconnection that prevented the onset of degeneration in the 412 distal axon. For clarification of successful fusion, animals were re-analysed at 48 hours and/or 72 413 hours post-axotomy as necessary. 414
For lifespan assays, 50 L4 stage animals were picked for each strain and moved to new plates every 415 day during the first 6 days and again at later days to avoid mixing with the progeny. Animals that did 416 not move after being touched with a platinum pick were scored as dead. Dead animals were 417 counted and removed every day. 'Bag of worms' and dry and burst animals were not included in the 418 lifespan analysis. The data was analysed using OASIS (Online application for Survival Analysis, 419 http://sbi.postech.ac.kr/oasis/) [55] . 420
For egg-laying and development assays, over 20 L4 stage animals per strain were picked separately 421 24 hours before the assay. On the day of the assay, two plates per strain were seeded with 422 concentrated OP50 E. coli and ten adults each deposited onto the plates. The adults were left to lay 423 eggs for 1.5 hours, removed from the plate and the eggs counted. Developmental stages were 424 determined at 48 and 61 hours, respectively, after egg-laying. 425
Dopamine paralysis assays were carried out as previously described [56] . Well-fed adults 24 hours 426 post the L4 stage were incubated for 20 min on a plate containing different concentrations of 427 dopamine. Animals were scored as paralysed when they failed to complete a full sinusoidal body 428 movement during a 5 second observation period. Two plates containing 25 animals each were 429 assessed for each condition. 430
Basal slowing assays were performed as previously described [57] . NGM plates were prepared and 431 half of them seeded with HB101 E. coli before incubating them at 37°C overnight. Also, mid-L4 larvae 432 were picked separately on seeded plates. The next day, these staged, well-fed young adult animals 433 were placed in 40 μL of M9 for 2 minutes to clean them from bacteria, and then picked to the centre 434 of a plate. 6 animals each were put on a plate with and without bacteria. After 2 minutes adaptation 435 time, the locomotion rate of each animal was quantified by counting the number of body bends 436 completed in five consecutive 20 s intervals. The experiment was performed twice on different days. 437 qRT-PCR 438 L1 stage animals were filtered using an 11 μm filter from two 9 cm plates containing mixed stage 439 animals. Animals were washed twice and the population was split in half for control treatment and 440 drug treatment. For the 6-OHDA assays, ascorbic acid and H 2 O was added to the control wells and 10 441 mM 6-OHDA to the treated animals. For paraquat assays, H 2 O was added to the control wells and 25 442 mM paraquat to the treated animals. After 1 hour of treatment, RNA extraction was performed 443 based on [58] using Trizol (Thermo Fisher Scientific). The following changes were introduced. The 444 chloroform extraction was repeated once more and 0.1 volumes of 3 M sodium acetate was added 445 to the propanol extraction to help RNA precipitation. The RNA pellet was resuspended in 15 μL H 2 O. 446
The gDNA was digested using the Turbo DNA-free kit (Ambion Life Technologies) in a total volume of 447 
Bioinformatics analysis 463
The open reading frame and exon-intron structure of ttr-33 was derived from information compiled 464 Expression Levels Locator) Version 2.0.3.r71 (http://spell.caltech.edu:3000/) were considered. Given 472 a query gene, SPELL searches for genes with correlated expression patterns based on available 473 microarray, RNAseq and tiling array data (currently 5264 experiments in 315 datasets). The main 474 algorithm is described in [69] . 475
Statistical analysis 476
The two-tailed t-test was performed with the Analysis ToolPak Add-In in Microsoft Excel 2010. To 477 choose between a t-test assuming equal or unequal variances, an F-test was conducted with the 478 Analysis ToolPak Add-In. A G-Test was performed with R Studio 1.0.44 DescTools descriptive 479 statistics tools package to compare 6-OHDA treatment data. p-values were calculated for each 480 biological replicate and for the pooled biological replicate data, and the least significant of these p-481 values is indicated in the graphs. Data is only marked as statistically significant if all replicates and 482 the pooled replicate data were found to be significant. Statistical analysis for axonal regeneration 483 was performed using GraphPad Prism and Microsoft Excel. Two-way comparison was performed 484 using the t-test. 485
DNA cloning and generation of transgenic lines 486
For generation of transgenic constructs, genomic DNA was amplified using primers containing 487 additional 8 base pair restriction sites (marked in italics) for insertion into the pCFJ151 and the 488 pCFJ212 vector for insertions on chromosome II and IV, respectively [70] . In the following primer 489 sequences, restriction sites are highlighted in italics, translation start and translation stop codons in 490 bold. Primers for the transcriptional reporter construct AscI -Pttr-33 -NotI -GFP -FseI -3'ttr-33 -491
PacI:
AscI_Pttr AGAAAAggccggcctTCTGTGAAGACAGTCACGTGACTC. The Pttr-33 promoter sequence in these 500 constructs ranges from -1500 to the translational start site. The predicted promoter sequence of ttr-501 33 ranges from -499 to 100 bp with respect to the translational start site [71] . Additional primers for 502 the translational construct AscI -Pbath-15 -NotI -TTR-33 -FseI -3'bath-15 -PacI: AscI_Pbath-15: 503
GTACTTggcgcgccTTTTCACTTTTTTTGGTCAGAATC, Pbath-15_NotI: 504
AAGGAAAAAAgcggccgccCATTTTGAAGAGTTTGCTG, FseI_3'bath-15: 505
CTCATAggccggccTAATCATTTTTTTCCTGTTTTAGC, 3'bath-15_PacI: 506
GAGACCttaattaaCTGGAGTTCACCACTACAAC. For single-copy integration of transgene according to 507
[70], the constructs were injected into unc-119 animals, together with one or two fluorescent 508 marker(s) (Pmyo-2::mCherry to label the pharynx and Pmyo-3::mCherry to label the bodywall), and 509 the Mos transposase under the control of the eft-3 promoter as described [72] . Wild-type moving 510 animals that did not show expression of fluorescent markers were singled out and tested for 511 transgene integration by PCR. At least three independent transgenic lines were analysed for all 512 translational and transcriptional constructs. Length of axonal regrowth in ttr-33(gt1983) mutants and wild-type animals (n.s. p>0.05; t-test). 777 Fig. ttr-33 mutant lifespan . 882
Figure captions
Lifespan data for second biological replicate including 85-110 animals per strain. The inset shows the 883 mean lifespan with the error bars depicting the standard error (****Bonferroni p≤0.0001; Log-Rank 884 Test). 885 S7 Fig. Transcript levels of ttr-33, gst-4, gcs-1 and gst-1 Fig. Transcript levels of ttr-33, gst-4, gcs-1 and gst-1 normalised against the control gene pmp-3 125 animals per strain. Total number of animals n = 150-350 (**p<0.01; two-tailed t-test). 923 S11 Fig. Alignment of C. elegans transthyretin-related 
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